Maybe. But Immuron could have easily got a thousand uni students paid them a thousand bucks to do the trial.
You could even run it double blind placebo bla blah.
Who cares if it means nothing to the FDA. You’ve got something meaningful to stick on your label and spruik to investors.
they could have had the whole thing done and dusted in 12 months.
nothing makes any sense here
Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-213
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
